Published in:
Open Access
01-12-2022 | Septicemia | Comment
Intravenous vitamin C in adults with sepsis in the intensive care unit: still LOV’IT?
Authors:
Christian Stoppe, Jean-Charles Preiser, Daniel de Backer, Gunnar Elke
Published in:
Critical Care
|
Issue 1/2022
Login to get access
Excerpt
The recent results of the lessening organ dysfunction with vitamin C (LOVIT) randomized controlled trial (RCT) have challenged the potentially beneficial role and brought concerns on the safety of high-dose vitamin C in patients with sepsis. Septic patients admitted to the intensive care unit (ICU) received either high-dose vitamin C or placebo. As opposed to placebo, vitamin C was associated with an increased occurrence of the primary endpoint (persistent organ dysfunction plus death) [
1]. While these results may suggest the end of the vitamin C story, several aspects suggest that LOVIT is just one piece of the puzzle and that the baby should not be thrown out with the bathwater. …